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Abstract
Background: Syphilis with ocular involvement has reemerged as a critical health problem. The aim of the present
study was to explore the clinical manifestations and cerebrospinal fluid (CSF) status in ocular syphilis in human
immunodeficiency virus (HIV)-negative patients.
Methods: The clinical records of patients with ocular syphilis presenting to the Shanghai Xuhui Central Hospital
in the period from January 2011 to December 2012 were retrospectively reviewed.
Results: The median age of 25 HIV-negative patients with ocular syphilis was 53 years, 18 patients (72.0 %) were
males and 7 (28.0 %) were females. None of them self-identified themselves as men who had sex with men
(MSM). The ocular lesions included: uveitis (13 cases), optic neuropathy (6 cases), retinal vasculitis (5 cases),
retinal detachment (3 cases), and neuroretinitis (4 cases). Serum toluidine red unheated serum test (TRUST)
titer ranged from 1 to 512, with a median of 64. Overall, 18 (72.0 %) of the 25 patients had abnormal CSF
results, 15 (60.0 %) CSF samples had elevated white blood cell counts, 13 (52.0 %) had elevated protein levels, and 9
(36.0 %) had reactive CSF Venereal Disease Research Laboratory (VDRL) test, respectively. Mann–Whitney U tests
showed higher serum TRUST titer (>32) correlated with the abnormal CSF results.
Conclusions: The demographic characteristics of patients with ocular syphilis in this study were different from
previous reports. The study showed a high CSF abnormal rate in HIV-negative patients. The recommendation for
CSF examination from all patients with ocular syphilis, including HIV-negative cases, is strongly supported by the
present data.
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Background
Syphilis is a chronic sexually transmitted disease caused
by a spirochete Treponema pallidum subsp. pallidum
that can affect most organ systems, including the eyes.
Syphilis has been considered as “the great masquerader”
and often presents with manifestations similar to various
other ocular diseases. It can involve all parts of the eye
and may be the only manifestation of syphilis. In the
pre-antibiotic era, syphilis was recognized as one of the
most common causes of intraocular inflammation. The
introduction of penicillin during the 1950s led to a
decrease in the incidence of syphilis; hence, vigilance
was required in the diagnosis of ocular syphilis [1, 2].
Even with no clinical evidence of central nervous sys-
tem (CNS) disease, the US Centers for Disease Control
and Prevention (CDC) recommended a standard regi-
men of intravenous penicillin for neurosyphilis at a dose
of 18–24 million units daily for 10–14 days [3]. Outside
of case reports or small case series, little is known about
the concomitant CNS involvement in ocular syphilis. A
significantly higher proportion of human immunodefi-
ciency virus (HIV)-positive patients with ocular syphilis
compared with HIV-negative cases have been reported
in published studies [4–8]. In a meta-analysis in HIV-
positive patients with ocular syphilis, 74 % had elevated
cerebrospinal fluid (CSF) white blood cell (WBC) count,
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75 % had elevated CSF protein while 57 % had positive
CSF Venereal Disease Research Laboratory (VDRL) test
[9]. Few data exist about the CSF status in ocular syph-
ilis in HIV-negative individuals. HIV increases the risk
for both neurosyphilis and CSF abnormalities [3]; there-
fore important questions remain about the relationship
between ocular syphilis and neurosyphilis. Uncertainties
exist in the optimal management of ocular manifesta-
tions of syphilis due to a lack of evidence.
The prevalence of syphilis has increased sharply in the
last decade in several countries around the world, including
China. Since the invention of penicillin, no country has
experienced such a dramatic upsurge of reported syphilis
cases, as China is presently having [10]. Nationwide surveil-
lance data indicated that the incidence of syphilis in the
general population increased from 0.17 cases per 100,000
in 1993 to 20.0 cases per 100,000 in 2010 [11]. Syphilis has
now become the most commonly reported communicable
disease in Shanghai, the largest city in China, with 76.42
cases per 100,000 reported in 2011 [11, 12]. Syphilis with
ocular involvement has reemerged as a critical health prob-
lem. A failure to recognize the ocular manifestations of
syphilis or delayed diagnosis and treatment can lead
to irreversible visual loss. For a better understanding
of HIV-negative patients with ocular syphilis, espe-
cially CSF status, a case series is presented here.
Methods
Study participants
Located in Shanghai, the Eye & ENT (Eye, Ear, and Throat)
Hospital of Fudan University is the biggest Eye and ENT
hospital in east China. Patients who visited the hospital
with eye, ear or throat-related symptoms suspected of syph-
ilis were suggested to have a blood screening for syphilis,
and those screened positive were transferred to Shanghai
Xuhui Central Hospital (Shanghai Clinical Center, Chinese
Academy of Science) for further treatment. All the patients
with ocular syphilis presenting to Shanghai Xuhui Central
Hospital were advised to have CSF examination. The clin-
ical records of patients with ocular syphilis in the period
from January 2011 to December 2012 were retrospectively
reviewed. Individuals were eligible for enrollment in this
study if they 1) presented initially with ocular symptoms 2)
had serological evidence of syphilis and 3) had completed
CSF examination. The collected data included chief com-
plaint, demographic data, cocurrent medical problems,
ophthalmologic findings, syphilis serology, HIV serology
and CSF examination results. Written informed consents
were obtained from all participants for lumbar puncture
according to the routine medical procedure.
Laboratory methods
Treponema pallidum particle agglutination (TPPA) tests
were conducted using the Serodia-TPPA reagent from
Fujirebio Diagnostics Inc (Malven, Pennsylvania, USA).
The results were observed according to the manufac-
turer’s instructions. Serum toluidine red unheated serum
test (TRUST) and CSF VDRL tests were performed ac-
cording to the standard methods. The TRUST reagents
were manufactured by Shanghai Rongsheng Biotech, and
the VDRL antigen with buffered saline were manufac-
tured by Becton-Dickinson and Company (Diagnostic
Systems, MD, USA). All patients underwent HIV screen-
ing through a dual enzyme-linked immunosorbent assay.
Statistical methods
Subjects with reactive CSF TPPA were classified as having
abnormal CSF if they also met one of the following criteria:
reactive CSF VDRL, elevated CSF WBC (>5 cells/mm3)
count, or elevated protein level (>45 mg/dL). Qualitative
variables were described using frequencies and percentages,
while quantitative variables were described using medians
and interquartile ranges (IQR). Mann–Whitney U-test was
used to compare variables between abnormal and normal
CSF subjects. Data were recorded using Microsoft Excel,
and analyses were performed using Statistical Package for
the Social Sciences (SPSS15.01, SPSS Inc.,, IL, USA).
Ethics statement
The Ethical Committee of the Shanghai Xuhui Central
Hospital (Shanghai Clinical Center, Chinese Academy of
Science) waived the need for institutional review board
approval because of the retrospective nature of this study.
The participants were not required to provide written
informed consent for their clinical records to be used in
this study. Patient information was anonymized and de-
identified prior to analysis. The described research adhered
to the principles of the Declaration of Helsinki.
Results
During the 2-year period, 25 patients with syphilis were
identified who initially presented with ocular symptoms
and completed CSF examination. All patients were treated
unsuccessfully with nonspecific therapy for ocular symp-
toms before the correct diagnosis was made. None of them
had a previous history of syphilis. The interval between
ocular symptom onset and the first visit at the hospital
ranged from 2 weeks to 20 years (median 4 months, IQR
13 month). The median age at presentation was 53 years
(range 30–77 years). All 25 patients were of Han ethnicity.
Eighteen patients (72.0 %) were males, and seven were
females (28.0 %). Twenty-four patients (17 males and 7 fe-
males) identified themselves as heterosexual; another male
refused to provide sexual partner information. One male
and three female patients got syphilis infections from their
spouses. Of the 25 patients, 3 (12 %) had mucocutaneous
manifestation of secondary syphilis, 5 (20 %) had a history
of papulomacular rash on the trunk and palms or soles of
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the feet, 2 (8 %) reported previous genital ulcers, and 15
(60 %) had no systemic signs. Ocular symptoms were bilat-
eral in 16 (64 %) cases. None of the 25 patients tested posi-
tive for HIV infection. The ocular lesions included: uveitis
(52 %,13 cases), optic neuropathy (24 %, 6 cases), retinal
vasculitis (20 %, 5 cases), retinal detachment (12 %, 3 cases),
and neuroretinitis (16 %, 4 cases). Six (24 %) patients had
multiple ocular lesions. Patients with comorbidities in-
cluded hypertension (20 %, five cases), diabetes mellitus
(24 %, six cases), tuberculosis infection (4 %, one case),
hepatitis C (4 %, one case), renal atrophy (4 %, one case),
cancer (4 %, one case), and hypercholesterolemia (8 %, two
cases). Clinical and CSF features of the 25 patients are pre-
sented in Table 1.
All patients had positive serum TPPA and TRUST re-
sults. The range of serum TRUST titer ranged from 1 to
512, with a median of 64. Overall, 18 (72.0 %) of the 25
patients had abnormal CSF results. Of which, 15(60.0 %)
CSF samples had elevated WBC counts, 13(52.0 %) had
elevated protein level, 9(36.0 %) had reactive CSF VDRL
test, respectively. The CSF cell count ranged from 0 to
154, with a median of 11cells/mm3 (normal ≤5 cells/mm3).
The CSF protein level ranged from 17 to 144, with a me-
dian of 46 mg/dl (normal ≤45 mg/dl). The CSF VDRL titer
ranged from 0 to 8.
Mann–Whitney U-test revealed that a higher serum
TRUST titer (>32) correlated with the abnormal CSF
results (P < 0.05). The other investigated factors in-
cluding age, gender, and interval between ocular dis-
ease onset and the diagnosis were not associated with
ocular syphilis (Table 2).
Discussion
During the 1960s to 1980s, no new case of ocular syph-
ilis was reported in China. However, dozens of cases
with ocular syphilis were reported from a single urban
setting in the past two years. This is in accordance with
recent syphilis epidemic in China [11, 12].
Most studies on ocular syphilis originated in the Western
world, and only a few studies have reported on the features
of this disease in Asian patients. In previous reports from
the United States, United Kingdom, France and other
Table 1 Demographic, clinical, and laboratory data of patient with ocular syphilis
Case Age/Sex Serum TRUST CSF- VDRL CSF- WBC cells/mm33 CSF- Protein mg/dL Ocular findings
1 M 128 N 11 1.44 Neuroretinitis
2 M 16 4 2 0.58 Retinal vasculitis
3 M 64 2 1 0.68 Uveitis, optic neuropathy
4 F 8 N 0 0.23 Uveitis, Neuroretinitis
5 F 16 4 1 0.50 Uveitis
6 F 2 N 0 0.31 Uveitis, retinal vasculitis
7 M 512 4 30 0.4 Uveitis
8 M 128 N 8 0.49 Neuroretinitis
9 M 4 N 3 0.32 Optic neuropathy
10 M 64 N 24 0.46 Retinal detachment
11 M 32 1 15 0.51 Uveitis
12 M 32 N 20 0.54 Uveitis
13 F 2 N 4 0.27 Uveitis
14 M 16 1 23 0.17 Retinal vasculitis
15 F 64 8 64 0.62 Uveitis, optic neuropathy
16 F 128 N 18 0.41 Uveitis, Neuroretinitis
17 M 1 N 4 0.37 Retinal detachment
18 M 4 N 4 0.30 Uveitis
19 M 64 N 12 0.54 Uveitis
20 M 4 N 0 0 Retinal vasculitis
21 M 64 N 41 0.286 Retinal detachment
22 F 64 N 29 0.53 Optic neuropathy
23 M 128 1 10 0.48 Optic neuropathy
24 M 128 N 16 0.3 Uveitis
25 M 64 8 154 0.66 Optic neuropathy
Dai et al. BMC Infectious Diseases  (2016) 16:245 Page 3 of 5
Western Europe countries, most of the increase in
the incidence of syphilis occurred among men, espe-
cially young men who had sex with men (MSM) and
was associated with the HIV epidemic [13–17]. Al-
though most patients here were males, none of them
indentified themselves as MSM, except for one male
who refused to provide sexual orientation; 12 of the
18 acknowledged a history of unprotected intercourse
with female sex workers. Most of the patients in this
study were in their fifties to sixties, our recent na-
tional survey among male clients with sexually trans-
mitted diseases in China has also shown that elder
patients were more likely to have syphilis infection
[18]. Older patients of low socio-economic status may
be more likely to visit low-fee female sex workers and
less likely to use condoms. Furthermore, unlike most
reports from Western countries, none of the patients
with ocular syphilis were HIV-positive in this study.
The result is in agreement with other reports from
China;despite a high syphilis rate in some high-risk
populations, the HIV infection rate is relatively low
[19, 20]. Demographic characteristics of ocular syph-
ilis in the present study were substantially different
compared with other reports. The patients in this co-
hort seemed to be more atypical. If patients are pre-
sumed to be in low-risk groups, delays in diagnosis
and therapy may be likely.
It is recommended that all patients with ocular com-
plications of syphilis involvement undergo a lumbar
puncture. However, most of the previous reports from
ophthalmologists were focused on ocular findings. No
large studies have been conducted to determine the in-
cidence of concomitant CNS involvement in patients
with ocular syphilis. Case series from the pre-HIV era
and pooled data in HIV-positive patients suggested that
most patients with ocular syphilis had an elevated WBC
count or total protein in the CSF, which is consistent
with the results of this study [9, 21]. Conflicting data
exist about the CSF VDRL results among patients with
ocular syphilis. Although up to 54 % HIV-positive pa-
tients showed reactive VDRL in pooled analysis, Spoor’s
study from the pre-HIV era found that none of the 50
individuals with ocular syphilis had a reactive CSF
VDRL [9, 21]. In the present study, all the patients
were HIV-negative, and nearly one third had a reactive
CSF-VDRL test. It is not surprising that HIV-positive
patients had a higher abnormal CSF rate than in HIV-
negative patients, since co-infection with HIV could
alter the severity of syphilis and increases the likelihood
of syphilitic CNS involvement. The discrepancy in CSF
characteristics of HIV-negative patients between Spoor’s
study and the present results could be explained as fol-
lows: Frist, the patient in this study had a higher serum
non-treponemal test (100 % had reactive serum TRUST,
median titer 64) compared with the Spoor’s report (only
24 % had reactive serum VDRL, titer up to 16) [21].
Second, our previous study showed that the predomin-
ant Treponema pallidum genotype in Shanghai was
14d/f (88.8 %), which was suspected to be a high-risk
neurosyphilis genotype [22].
The present study found that patients with ocular
syphilis having a higher serum TRUST titer (>32) sig-
nificantly associated with an abnormal CSF. Other in-
vestigated factors including age, gender, and interval
between ocular disease onset and the diagnosis were
not associated with ocular syphilis. These findings are
consistent with the previous reports that found a rela-
tionship between higher serum non-treponemal test
(≥32) and neurosyphilis [22]. This might better ex-
plain why the present study had a higher CSF-VDRL
compared with the Spoor’s study.
This study had several limitations. First, the clinical
data were collected from a single center and the study
was retrospective, therefore, both selection and infor-
mation biases should be acknowledged. Second, the
sample size was relatively small, limiting the ability to
control confounding variables and perform multiple
statistical analyses. Third, syphilis has no pathogno-
monic ocular presentation. Polymerase chain reaction
of aqueous and vitreous humor, can help in making an
accurate diagnosis, and hence may be performed in fu-
ture studies.
Conclusions
The present study showed a high CSF abnormal rate
in HIV-negative patients with ocular syphilis. The rec-
ommendation for CSF examination from all patients
with ocular syphilis including HIV-negative cases is
Table 2 Variables associated with abnormal CSF
Normal CSF Abnormal CSF
Categorical variables Freq (%) Freq (%) P
Gender 0.355
Male (n = 18) 4 (22.2) 14 (77.8)
Female (n = 7) 3 (42.9) 4 (57.1)
Age 0.378
≤ 50 (n = 10) 4(40.0) 6 (60.0)
> 50 (n = 15) 3 (20.0) 12 (80.0)
Basic Serum TRUST <0.001
≤ 32(n = 12) 6 (50.0) 6 (50.0)
> 32(n = 13) 1 (7.7) 12 (92.3)
Duration 0.550
≤ 3 month (n = 12) 3 (25.0) 9 (75.0)
> 3 month (n = 13) 4 (30.8) 9 (69.2)
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strongly supported by the present data. More research
is needed to better understand ocular syphilis among
HIV-negative patients.
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